(4R,5S)-3-tert-Butyl 4-methyl 2,2,5-trimethyloxazolidine-3,4-dicarboxylate

Catalog No. :
ACRBUF037
CAS No. :
1013028-26-6
Molecular Formula :
C13H23NO5
Molecular Weight :
273.33

IUPAC Name:3-(tert-butyl) 4-methyl (4R,5S)-2,2,5-trimethyloxazolidine-3,4-dicarboxylate

(4R,5S)-3-tert-Butyl 4-methyl 2,2,5-trimethyloxazolidine-3,4-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$96.00Login to see priceInquiryInquiry
5g96%$441.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4R,5S)-3-tert-Butyl 4-methyl 2,2,5-trimethyloxazolidine-3,4-dicarboxylate
IUPAC Name3-(tert-butyl) 4-methyl (4R,5S)-2,2,5-trimethyloxazolidine-3,4-dicarboxylate
MDL No.MFCD21609189
Molecular FormulaC13H23NO5
Molecular Weight273.33
SMILESO=C(N1C(C)(C)O[C@@H](C)[C@@H]1C(OC)=O)OC(C)(C)C
InChI KeyFRSJJRXFHYGDSO-DTWKUNHWSA-N
Synonym(4 | R | ,5 | S | )-2,2,5-Trimethyloxazolidine-3,4-dicarboxylic Acid 3- | tert | -Butyl 4-Methyl Ester | (4 | R | ,5 | S | )-3-Boc-4-methoxycarbonyl-2,2,5-trimethyl-1,3-oxazolidine
CAS No.1013028-26-6
PubChem CID39871806

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACRBUF037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRBUF037 route product structure diagram
    ACRBUF0371013028-26-6
Inquiry

2. ACRBUF037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRBUF037 route product structure diagram
    ACRBUF0371013028-26-6
Inquiry

Comments (0)